Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Express Scripts
Cantor Fitzgerald
Harvard Business School

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,466,861

« Back to Dashboard

Summary for Patent: 5,466,861

Title: Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
Abstract:Bridged bicyclic aromatic compounds are provided having the structure ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and n are as defined herein. The novel compounds are useful for modulating gene expression of retinoic acid receptors, vitamin D receptors and thyroid receptors. Pharmaceutical compositions and methods for modulating gene expression are provided as well.
Inventor(s): Dawson; Marcia L. (Menlo Park, CA), Cameron; James F. (Palo Alto, CA), Hobbs; Peter D. (Moss Beach, CA), Jong; Ling (Sunnyvale, CA), Pfahl; Magnus (Solana Beach, CA), Zhang; Xiao-kun (La Jolla, CA), Lehmann; Jurgen M. (Solana Beach, CA)
Assignee: SRI International (Menlo Park, CA) La Jolla Cancer Research Foundation (La Jolla, CA)
Application Number:07/982,305
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

International Patent Family for Patent: 5,466,861

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2007001982► Subscribe
Brazil9307528► Subscribe
Canada2149882► Subscribe
European Patent Office0671005► Subscribe
JapanH08506323► Subscribe
Australia5869394► Subscribe
Japan2004159664► Subscribe
Australia4636893► Subscribe
Australia700706► Subscribe
World Intellectual Property Organization (WIPO)9325223► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Queensland Health
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus